Full Episode
Tuesday, Sep 30
PBS NewsHour
  • Episodes
  • Podcasts
  • Newsletters
  • The Latest
  • Politics
    Politics
    • Brooks and Capehart
    • Politics Monday
    • Supreme Court
  • Arts
    Arts
    • CANVAS
    • Poetry
    • Now Read This
  • Nation
    Nation
    • Supreme Court
    • Race Matters
    • Essays
    • Brief But Spectacular
  • World
    World
    • Agents for Change
  • Economy
    Economy
    • Making Sen$e
    • Paul Solman
  • Science
    Science
    • The Leading Edge
    • ScienceScope
    • Basic Research
    • Innovation and Invention
  • Health
    Health
    • Long-Term Care
  • Education
    Education
    • Teachers' Lounge
    • Student Reporting Labs
  • For Teachers
    Education
    • Newshour Classroom
  • About
    • Feedback
    • Funders
    • Support
    • Jobs

A free press is a cornerstone of a healthy democracy

Support trusted journalism and civil dialogue
Donate now
PBS News

Get news alerts from PBS News

Turn on desktop notifications?

venture capitalist

  • Full Episodes
  • Podcasts
  • Newsletters
  • Live
A customer is escorted into the Silicon Valley Bank headquarters in Santa Clara, California, U.S., March 13, 2023. Photo by Brittany Hosea-Small/REUTERS

Economy Mar 14

Class action lawsuit filed against Silicon Valley Bank parent company

By Michelle Chapman, Associated Press

Economy Sep 20

The best way to get the inside track on job openings is to get to know the people who work in the industry, writes columnist Nick Corcodilos. Photo by Robert Galbraith/Reuters
Column: Why you no longer need a venture capitalist to start a successful business

The spread of the virtual corporation model was a boon for generic plug-and-play vendors who could assemble products and manage supply chains, ship goods to consumers and provide various business services. But once all of these components were available off-the-shelf,…

By Gerald Davis

Science Jul 18

No image
Biotech Companies, Investors Look to Adult Stem Cell Research

In June, pharmaceutical giant Pfizer announced that it was investing $3 million in a small San Diego-based biotech startup called EyeCyte, which will work to develop adult stem cell-based treatments for eye diseases.

By Admin, PBS News Hour

Support Provided By: Learn more

web ad

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Full Episode
Tuesday, Sep 30
  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You
  • Friends of the News Hour
PBS News

© 1996 - 2025 NewsHour Productions LLC. All Rights Reserved.

PBS is a 501(c)(3) not-for-profit organization.

Sections

  • The Latest
  • Politics
  • Arts
  • Nation
  • World
  • Economy
  • Science
  • Health
  • Education

About

  • About Us
  • TV Schedule
  • Press
  • Feedback
  • Funders
  • Support
  • Newsletters
  • Podcasts
  • Jobs
  • Privacy
  • Terms of Use

Stay Connected

  • Facebook
  • YouTube
  • Instagram
  • X
  • TikTok
  • Threads
  • RSS

Subscribe to Here's the Deal with Lisa Desjardins

Form error message goes here.

Thank you. Please check your inbox to confirm.

Support our journalism

Support for News Hour Provided By

  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You